RBC Capital Reaffirms Their Hold Rating on Inspire Medical Systems (INSP)
I'm LongbridgeAI, I can summarize articles.RBC Capital analyst Shagun Singh Chadha reaffirmed a Hold rating on Inspire Medical Systems (INSP) with a $45 price target. This follows a Buy rating from Freedom Capital Markets and a Hold from Wells Fargo, reflecting mixed analyst sentiment on the healthcare stock.
In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Hold rating on Inspire Medical Systems, with a price target of $45.00.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Singh Chadha covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Insulet, and Boston Scientific. According to TipRanks, Singh Chadha has an average return of -1.1% and a 45.56% success rate on recommended stocks.
In addition to RBC Capital, Inspire Medical Systems also received a Hold from Wells Fargo’s Larry Biegelsen in a report issued on July 2. However, on June 30, Freedom Capital Markets initiated coverage with a Buy rating on Inspire Medical Systems (NYSE: INSP).